2280results about "Veterinary instruments" patented technology

A redundant temperature monitoring system and method for an electrosurgical system are provided. The temperature monitoring circuit includes at least one temperature sensor for sensing a temperature at a measuring point, a first temperature measurement circuit coupled to the at least one temperature sensor for generating a first temperature value, a second temperature measurement circuit coupled to the at least one temperature sensor for generating a second temperature value, and a control circuit for determining a difference between the first and second temperature values and for comparing the difference to a first predetermined threshold. If the difference is greater than the first predetermined threshold, the control circuit generates a warning signal. If the difference is greater than a second predetermined threshold, the control circuit generates an alarm signal and / or shuts down a power source of the electrosurgical system.

A jet injector system for injecting fluid into a body. The jet injection system includes capsules for holding the material to be injected, apparatus for applying force to the capsule(s) to eject the injection material(s) and a perforator for directing the jet stream for the respective materials into the body. A flyweight system is described for developing jet injection pressures, and latching devices control the flyweight system. An injector system for injecting more than one fluid is described.

A metered dose inhaler including a mechanism for agitating the medicament formulation prior to its separation in a measured dose, for administration to a mammal, including a human. The separated dose is a homogeneous mixture of prescribed medicine in a fluid carrier.

A needle-free transdermal transport device for transferring a substance across a surface of a biological body includes a reservoir for storing the substance, a nozzle in fluid communication with the reservoir and a controllable electromagnetic actuator in communication with the reservoir. The actuator, referred to as a Lorentz force actuator, includes a stationary magnet assembly and a moving coil assembly. The coil assembly moves a piston having an end portion positioned within the reservoir. The actuator receives an electrical input and generates in response a corresponding force acting on the piston and causing a needle-free transfer of the substance between the reservoir and the biological body. The magnitude, direction and duration of the force are dynamically controlled (e.g., servo-controlled) by the electrical input and can be altered during the course of an actuation cycle. Beneficially, the actuator can be moved in different directions according to the electrical input.

A substance delivery device capable of insertion into a body cavity of an animal, with the delivery device including a body capable of housing a delivery apparatus capable of actively being controlled to autonomously deliver at least one substance into a body cavity of an animal, with the delivery apparatus including dedicated pressure systems to deliver the at least one substance from independent reservoirs via at least one associated outlet, with the at least one substance ranging in form from substantially fluid to substantially solid, with the device also including a programmable control device capable of initiating and regulating delivery of the at least one substance in accordance with a preferred delivery regime, and with the body further including a tail portion adapted to receive retention apparatus external to the animal and capable of effecting retention of the substance delivery device within the body cavity of an animal.

In an automatic milking installation including a robot arm (2) with a gripper (3) for attaching teat cups (4) to the teats of an animal, e.g. a cow, to be milked, for applying a teat dip to the teats after milking different members, such as spray nozzles (5a, 5b), dipping cups (5c, 5d) and sponge or cloth rollers (5e), are provided for applying different teat dip compositions. Under the control of a computer, the robot arm collects the member (5) appropriate for supplying the selected composition and takes it to a position appropriate for application of that composition. The selection can e effected in dependence upon the teat skin condition, e.g. detected by a camera (15) and / or environmental conditions.

An intradermal delivery device for use in intradermally injecting substances into the skin of an animal includes a needle cannula supported by a hub portion that is attachable to a prefillable container. A limiter portion surrounds the needle cannula and extends away from the hub portion toward a forward tip of the needle cannula. The limiter portion includes a skin engaging surface extending in a plane generally perpendicular to an axis of the needle cannula. The skin engaging surface is received against skin of an animal to administer an intradermal injection. The forward tip extends beyond the skin engaging surface a distance that enables penetration of the needle cannula into the dermis layer of the skin of the animal enabling injection of the substance into the dermis layer of the animal. The device includes enclosure means that is moveable for concealing the needle cannula after the injection has been administered.

A mask (10) for use with a system for supplying breathable gas pressurised above atmospheric pressure to a human or animal's airways. The mask (10) includes a mask shell (12) which is, in use, in fluid communication with a gas supply conduit (30), and a gas washout vent assembly (20). At least the region of the mask shell (12) or conduit (30) surrounding or adjacent the vent assembly is formed from a relatively flexible elastomeric material.

The present invention relates to pharmaceutical compositions for the treatment and / or prophylaxis of disease associated with fibrosis in a vertebrate, said composition comprising at least one activin antagonist, and optionally a pharmaceutically acceptable carrier, adjuvant and / or diluent. The invention also relates to methods of treatment of disease associated with fibrosis in a vertebrate, as well as methods for diagnosing such conditions, and kits therefor.

An apparatus for the automatic delivery to an animal of a beneficial agent such as analgesia by infusion with the pain of the animal being taken into account when determining the rate of dispensing the agent. As the pain experienced by an animal and therefore its distress is manifested in increased agitation, the apparatus includes elements for the measurement of the frequency and amplitude of an animal's movement and the generation of a trigger signal when the either the frequency or the amplitude exceeds a predetermined threshold. The trigger can be used to generate a visual or audible alarm. The apparatus also preferably includes a dispensing means for delivering doses of beneficial agent to the animal in response to the trigger signal. The apparatus serves primarily to reduce the post-operative distress experienced by an animal by providing for timely administration of analgesic compounds. The apparatus also aids the animal care-giver by reducing the amount of time spent assessing the animal and administering beneficial compounds.

The present invention relates to constructs and methods used to enhance the attachment and implantation of an embryo. It is shown that modified glycolipids and glycolipid-attachment molecule constructs can be used to modify embryos, or localised to target tissues, to enhance interaction between the embryo and the target tissue, (typically the endometrium). The invention may advantageously be used to enhance implantation of embryos in the uterus, for example, in IVF treatments.

Hand-held dispensing devices for dispensing and applying a substance to the skin of a host are described. The devices include a hollow body, a capsule mounted within the hollow body for containing the substance, a nozzle mounted within the hollow body communicating with the substance in the capsule, an actuator to cause metered quantities of the substance to be dispensed from the capsule through the nozzle, a shroud defining an exit space for receiving the substance emerging from the nozzle, and a cap detachably mounted on the shroud to selectively open and close the nozzle and thereby control escape of the substance from the capsule.

A needle-free transdermal transport device for transferring a substance across a surface of a biological body includes a reservoir for storing the substance, a nozzle in fluid communication with the reservoir and a controllable electromagnetic actuator in communication with the reservoir. The actuator, referred to as a Lorentz force actuator, includes a stationary magnet assembly and a moving coil assembly. The coil assembly moves a piston having an end portion positioned within the reservoir. The actuator receives an electrical input and generates in response a corresponding force acting on the piston and causing a needle-free transfer of the substance between the reservoir and the biological body. The magnitude, direction and duration of the force are dynamically controlled (e.g., servo-controlled) by the electrical input and can be altered during the course of an actuation cycle. Beneficially, the actuator can be moved in different directions according to the electrical input.

A method and apparatus of dispensing a radiopharmaceutical wherein a source of flushing fluid is connected to a first port of a fluid delivery set; a pressurizing unit of a powered injector system (including a powered injector and the pressurizing unit) is connected to a second port of the fluid delivery set; air is purged from the fluid delivery set; and, after purging air from the fluid delivery set, a third port of the fluid delivery set is connected to a source of the radiopharmaceutical. A valve system is included to control flow of fluid. A syringe is operatively connected with a powered injector. A radioactive shield encloses the syringe during operation to protect personnel from detrimental effects. A dose calibrator measure the radioactivity in the syringe.

A noninvasive photoplethysmographic sensor platform for mobile animals such as small rodents, namely rats and mice is useful such as in a laboratory research environment. The noninvasive photoplethysmographic sensor platform may be a collar which provides an easily affixed, adjustable attachment mechanism that encircles the animal, such as the neck. The neck of the animal provides several particular advantages as a sensor mounting platform for photoplethysmographic sensors. For pulse oximetry, the neck location will provide significant blood flow under all conditions. For small mammals, such as rats and mice, transmittance pulse oximetry through the neck of the subject remains possible. The neck mounted collar also offers inherent bite resistance to the sensor platform.

The invention provides therapeutic methods and products for the treatment of inflammation, inflammatory diseases and conditions, and proliferative diseases and conditions. The invention also provides methods and products for inhibiting inflammation in excised cells, tissues and organs. The invention further provides oral care methods and products for the treatment of the tissues of an animal's mouth. Finally, the invention provides personal care methods and products for the treatment of the skin of an animal. All of these methods and products utilize N-acyl-L-aspartic acid or an ester or pharmaceutically-acceptable salt thereof.

Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and / or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.

A method and system for infusing and monitoring a tethered laboratory animal includes a platform suitable for carrying the laboratory animal. A tether assembly includes a flexible conduit for connecting to the animal and a tether for tethering the animal. A torque sensor detects a motion of the animal and drives the tether assembly in response to the detected motion of the animal, and thereby reduces the torque on the animal. The platform is driven in a direction opposite to the tether assembly so that it appears to be stationary when the tether assembly is driven in response to a detected motion of the animal.

A method for administration of a substance into the dermis of a mammal is disclosed. The method involves administration into the dermis by injection which results in improved systemic absorption relative to that obtained upon subcutaneous administration of the substance. The substance administered may be a growth hormone, a low molecular weight heparin or a dopamine receptor agonist.

The present invention relates to a method of identifying a gene or gene product associated with transcription dependent memory formation in an animal comprising the steps of: (a) administering to said animal sufficient small interfering RNA (siRNA) specific for the gene to inhibit gene function; (b) training said animal under conditions sufficient to induce transcription dependent memory formation in a normal untreated animal; and (c) determining the level of transcription dependent memory formation induced by the training of the treated animal. The present invention provides methods of using small interfering PNAs (siRNA) in hippocampus to identify genes and gene product whose inhibition affects contextual and temporal long-term (LTM) memory, but not short-term memory (STM).

A system and method are provided for transducing vaginal conditions, affecting vaginal or body conditions, and / or stimulating perineal musculature and nerves. A separate, portable, non-implanted intravaginally containable combination probe and transceiver is provided that can sense vaginal conditions, can deliver signals or medication, and / or can stimulate perineal musculature and nerves. This probe unit is provided with 2-way wireless communication for transmitting information that is transduced and for receiving control and programming signals. In addition, a separate combination controller and transceiver is provided for wirelessly sending signals to the probe unit and for receiving signals therefrom. A real time wireless signal feedback loop is thus provided between the controller and the probe and / or external devices, networks and databases.

Described is a catheter system for implanting embryos into a woman's uterus. The catheter system utilizes a protective catheter sleeve for introducing a catheter into the uterus without mucus contamination of an inner catheter. Once the sleeve containing the inner catheter is introduced into the uterus, the protected inner catheter, carrying the embryos, is pushed through a swivelable distal end cap on the sleeve to a desired implanting location. The distal end of the inner catheter has a protective cap and a side opening for embryo release. Also, stiffness and indicia features of the outer sleeve and inner catheter assist in the physician's handling of the catheter system and in ensuring a desired uterus location for implanting.

The present invention relates to a system for measuring respiratory function of living organisms. More particularly, signals indicative of the change in lung volume, defined as active and passive work, required to breathe and the airflow through the respiratory system of the living organism are obtained and processed as waveforms to provide a signal indicative of the respiratory restriction. The methods of the present invention measure clinical forms of airway obstruction, airway reactivity and lung volume and may be used to continuously or intermittently monitor patients with compromised respiratory function. In a preferred embodiment, a head-out, breath in respiratory plethysmograph system provides the signals indicative of change in lung volume as related to pressure changes in a chamber. Further, flowmetric variables are generated that provide a characterization of airway obstructions.

Medicine delivery interface for delivery of therapeutic aerosols or gases, including at least one hollow body having at least one nasal aperture defined therein at least one nasal insert tube associated with each nasal aperture of the hollow body is capable of being inserted into a nostril. The interface also may include at least one exhaust aperture having at least one exhaust valve configured to exhaust exhaled gases and configured to block inflow of air through the exhaust aperture and at least one intake aperture.

An intradermal needle assembly that is attachable to a prefillable container intended for intradermally injecting substances into an animal includes a needle cannula supported by a hub portion. The hub portion is adapted to receive the prefillable container just prior to administering the intradermal injection. A limiter portion surrounds the needle cannula and extends away from the hub portion toward a forward tip of the needle cannula, and includes a skin engaging surface with the needle cannula having a fixed angle of orientation, preferably generally perpendicular, relative to the plane of the skin engaging surface. The skin engaging surface is received against the skin of an animal to administer an intradermal injection. The forward tip extends beyond the skin engaging surface a distance enabling penetration of the needle cannula into the dermis layer of the skin of the animal enabling injection of the substance into the dermis layer.

The invention provides methods for delivering a therapeutic or diagnostic agent to the eye of a mammal. The method involves contacting sclera with a therapeutic or diagnostic agent so as to permit its passage through the sclera into the choroidal and retinal tissues. The sclera may be contacted with a therapeutic or diagnostic agent together with a device for enhancing transport of the agent through the sclera.

A device designed to take rotary power from an external power source such as a cordless electric screwdriver and transmit that energy into both rotary and reciprocating linear activation of sexual devices used by both males and females for the purpose of masturbation and auto-stimulation is disclosed. The combination of rotational stimulation with reciprocating linear stimulation is apparently remarkably satisfying despite the absence of such stimulation during normal person-on-person sexual contact. The device is simple, light weight, small, powerful, modestly priced, handheld or hands-free, user serviceable, hygienic, gender neutral, sexual orientation neutral, convenient, rugged, multi-motion, safe, reliable, quiet, fully submersible, positionally versatile and sexually satisfying.

A drug delivery system is disclosed which may be a throwaway or reusable device for delivery at least one drug to a patient. Also described is a method for administering a drug using said device and a packaged drug for use with said device. The drug delivery device (10) comprises a housing (12), a means (14) for generating a force capable of pushing a drug (16) from a packaging (18) into a human or animal body, a means (20) for transmitting said force to push the drug (16) from the packaging (18) into the human and animal body, and a means (38, 42b) for triggering the device. Where the device is a single use drug delivery (10) a packaged drug (100) forms an integral part of the device. The packaged drug (100) comprises packaging (18) containing a drug (16), having a housing (18a, 18b) wit a channel (106) running there through and in which is disposed a drive pin or other element (108), a skin piercing means (110, 112), and the drug (16), said housing (18a, 18b) further comprising a region (102) allowing the packaged drug (100) to be slidably mounted to the drug delivery device (10) and an end (104) adapted to engage and tension the skin.

PCT No. PCT / JP96 / 02503 Sec. 371 Date Mar. 2, 1998 Sec. 102(e) Date Mar. 2, 1998 PCT Filed Sep. 4, 1996 PCT Pub. No. WO97 / 08946 PCT Pub. Date Mar. 13, 1997The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.